List of Excipients in API indium in-111 oxyquinoline
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing indium in-111 oxyquinoline
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Medi-Physics Inc dba GE Healthcare | INDIUM IN 111 OXYQUINOLINE | indium in-111 oxyquinoline | 17156-021 | POLYSORBATE 80 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing indium in-111 oxyquinoline
Detailed excipient profiles for indium in-111 oxyquinoline
Excipient focus: HYDROCHLORIC ACID
indium in-111 oxyquinoline drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
BWXT Medical Ltd | indium in-111 oxyquinoline | 72536-0920 |
>Company | >Ingredient | >NDC |
indium in-111 oxyquinoline drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Medi-Physics Inc dba GE Healthcare | indium in-111 oxyquinoline | 17156-021 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
indium in-111 oxyquinoline drug variants containing HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
Company | Ingredient | NDC |
---|---|---|
BWXT Medical Ltd | indium in-111 oxyquinoline | 72536-0920 |
>Company | >Ingredient | >NDC |
indium in-111 oxyquinoline drug variants not containing HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
Company | Ingredient | NDC |
---|---|---|
Medi-Physics Inc dba GE Healthcare | indium in-111 oxyquinoline | 17156-021 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
indium in-111 oxyquinoline drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Medi-Physics Inc dba GE Healthcare | indium in-111 oxyquinoline | 17156-021 |
BWXT Medical Ltd | indium in-111 oxyquinoline | 72536-0920 |
>Company | >Ingredient | >NDC |
indium in-111 oxyquinoline drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
indium in-111 oxyquinoline drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
BWXT Medical Ltd | indium in-111 oxyquinoline | 72536-0920 |
>Company | >Ingredient | >NDC |
indium in-111 oxyquinoline drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Medi-Physics Inc dba GE Healthcare | indium in-111 oxyquinoline | 17156-021 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
indium in-111 oxyquinoline drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
BWXT Medical Ltd | indium in-111 oxyquinoline | 72536-0920 |
>Company | >Ingredient | >NDC |
indium in-111 oxyquinoline drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Medi-Physics Inc dba GE Healthcare | indium in-111 oxyquinoline | 17156-021 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.